<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210526051412N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-06-05</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The comparison of clinical outcome of early motion versus late motion following arthroscopic repair of rotator cuff tearing; Randomized Clinical Trial Study</public_title>
      <acronym></acronym>
      <scientific_title>The comparison of clinical outcome of early motion versus late motion following arthroscopic repair of rotator cuff tearing; Randomized Clinical Trial Study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/56571</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, we use the restricted randomization method
randomization (block randomization type
randomization (we will use. blocking usually in order
Balance the number of samples assigned to each group
To be used in the study. This feature helps researchers to
Items that require intermediate analyzes during the sampling process
The number of samples assigned to each of the case groups
The study is equal. The size of all the blocks is equal and we are in this
Two-group trial of 6 blocks (including 3 participants in
We will have an intervention group and 3 participants in the control group. Randomization tools are also used in sequence generation software
Random (software allocation Random) is used that
Random sequence generation software in addition to simple randomization capable
To produce random sequences by block generation method. For hiding
We avoid concealment allocation
We use the method used to execute the sequence
Random refers to study participants, in a way
That before the individual is assigned, the assigned group is not specified. With
From opaque envelopes sealed in random sequence
(envelopes opaque, sealed, numbered Sequentially )
This method uses each of the random sequences created on a card
It is registered and the cards are placed in the letter envelopes in order
To be. In order to maintain a random sequence, also on the outer surface of the envelope
The numbering is done in the same way. Finally the envelope door
The letters are pasted and placed in a box, respectively. At
Time to start registration of participants, based on the order of entry of the company
Eligible applicants to open one of the envelopes in order
And the assigned group of the participant will be revealed, Blinding description: The study will be blinded one way. Patients according to type
Interventions will not be blinded. The researcher must enter the data into the checklist
The corresponding slow will be blinded to the type of intervention. The person in charge of the clinical care of the patients, as well as the physiotherapist, will not be blinded.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Arthropocytic treatment of rotator cuff tear.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Physiotherapy is performed immediately after arthroscopic repair surgery, ie from the day after the operation. The duration of each session is 30 minutes and 3 sessions per week and the total number of sessions is 30 sessions. TENS, IR, EXE, US modals will be used equally in all patients. All patients with inactive shoulder movements will start from the first session. . All patients will receive physiotherapy at a center by a physiotherapist. Intervention 2: Control group: Shoulder physiotherapy 4 weeks after arthroscopic repair surgery begins as 3 sessions of shoulder physiotherapy per week with 30 sessions with the emphasis on passive movements and performing tens and exercise and ultrasound and IR.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
In this section, patient information such as age, sex, and body mass index are published publicly, but patient names are not published.

When:
After confirming the ERCT code, we will start the study and 8 months later the data will be available to the public

To whom:
It will be available only to researchers working in academic and scientific institutions

Conditions:
We will make the data available to reputable scientific journals or orthopedic field research researchers in an unidentifiable individual manner.

Where to obtain:
1- Email correctly to sadulasharifpour@gmail.com
2- Call the mobile number 09214736009

How to obtain:
The applicant will be provided with the identity of the applicant within one week after the initial request

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sadula Sharifpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Office of the Director of the Orthopedic Department. Imam Khomeini Hospital Complex. End of Keshavarz Boulevard.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1418813675</zip>
        <telephone>+98 21 6643 5786</telephone>
        <email>sadulasharifpour@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nima Bagheri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sabet Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1418813675</zip>
        <telephone>+98 21 6643 5786</telephone>
        <email>nimab1360@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with full-thickness rotator cuff rupture diagnosed by MRI include patients with acute rupture or chronic rupture
Ruptures involving only the supraspinatus on a grade 1 or grade 2 coronary MR</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1 - Age under 18 years
2 - Other diseases of the shoulder joint such as infection, avascular necrosis and so on
Major medical disease that makes it unlikely to live under 2 years
4. A specific psychiatric illness that impairs the possibility of conscious satisfaction
.5 - Inability to speak or read Persian
6 - Large ruptures or massive rotator cuff with extension to the subscapularis and minor fear
7 - Simultaneous pathology in labrum that requires surgery
8 - Simultaneous pathology in the acromioclavicular joint that requires distal clavicle resection.
9- Age over 70 years</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M75.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Rotator cuff tear or rupture, not specified as traumatic</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Physiotherapy is performed immediately after arthroscopic repair surgery, ie from the day after the operation. The duration of each session is 30 minutes and 3 sessions per week and the total number of sessions is 30 sessions. TENS, IR, EXE, US modals will be used equally in all patients. All patients with inactive shoulder movements will start from the first session. . All patients will receive physiotherapy at a center by a physiotherapist.</i_keyword>
      <i_keyword>Control group: Shoulder physiotherapy 4 weeks after arthroscopic repair surgery begins as 3 sessions of shoulder physiotherapy per week with 30 sessions with the emphasis on passive movements and performing tens and exercise and ultrasound and IR.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>In this study, we want to compare the amount of shoulder forward flexion based on the physiotherapy group immediately and the physiotherapy group 4 weeks later. Timepoint: It is at intervals of 3, 6 weeks, 3, and 6 months after rotator cuff arthroscopic repair. weeks, 3 months, and six months. will be measured. Method of measurement: With a questionnaire and through the scoring system is the Constant Murley scoring system, which scores between zero and one hundred.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Ultrasound 6 after arthroscopic repair of rotator cuff tearing. Timepoint: 6 months after surgery. Method of measurement: By sonography and according to the criteria of Sugaya and radiologist.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice Chancellor for Research and Technology, Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-09-01</approval_date>
        <contact_name>Ethics committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>Tehran, Keshavarz Blvd., Imam Khomeini Hospital tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
